Imexpharm Corporation manufactures, processes, trades, imports, and exports pharmaceutical products in Vietnam and internationally. The company’s products include oral and injectable antibiotic, digestion, central nervous system, cardiovascular, diabetes, musculoskeletal system, respiratory system, analgesic-anti-inflammatory, anti-histamines, anti-allergy, ophthalmology, external drugs, and anti-parasitic, as well as vitamins and minerals. It is also involved in the import and export of medical equipment and supplies, chemicals, materials for medicine manufacturing and packaging, and chemicals used for sterilization or disinfection in humans. The company was founded in 1977 and is headquartered in Cao Lanh, Vietnam.
Metrics to compare | IMP | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipIMPPeersSector | |
---|---|---|---|---|
P/E Ratio | 32.5x | 16.8x | −0.6x | |
PEG Ratio | −4.14 | −0.34 | 0.00 | |
Price / Book | 3.6x | 2.2x | 2.6x | |
Price / LTM Sales | 3.5x | 1.5x | 3.2x | |
Upside (Analyst Target) | −23.7% | 8.7% | 48.5% | |
Fair Value Upside | Unlock | 5.0% | 7.8% | Unlock |